Study of ITCA 650 (Exenatide in DUROS) in Subjects With Type 2 Diabetes Mellitus
NCT00943917
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
155
Enrollment
INDUSTRY
Sponsor class
Conditions
Type 2 Diabetes
Interventions
OTHER:
ITCA 650
DRUG:
Exenatide Injection
OTHER:
Ex Inj/ITCA 650
Sponsor
Intarcia Therapeutics